Hemofilili hastalarda HCV RNA'sının PCR'la taranması

1. Esteban R, Esteban JI, Lopez-Talavera JC, et al. Epidemiology of Hepatitis C virus infection. In Hollinger FB, Lemon SN, Margolis H (eds). Viral Hepatitis and Liver Disease. Baltimore, Williams and Wilkins, 1991; 413- 4.
2. Houghton M, Richman K, Han J, et al. Hepatitis C virus: A relative of the pestiviruses and flaviviruses. In Hollinger FB, Lemon SN, Margolis H, (eds). Viral hepatitis and Liver disease. Baltimore,Williams and Wilkins, 1991; 323-33.
3. Hollinger FB, Lin HJ. Community-acquired hepatitis C virus infection (editorial). Gastroenterology 1992; 102:1426-9.
4. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with polymerase chain reaction assay. Proc Nat Acad Sci USA 1992; 89: 187-91.
5. Cristiano K, Di Bisceglie AM, Hoofnagle JH, et al. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991;14:51-5.
6. Farci P, Alter HJ, Wong D, et al. A long -term study of hepatitis C virus replication in non-A, non-B hepatitis. N
Eng J Med 1991; 325:98-104.
7. Garson JA,Tedder RS, Briggs M, et al. Detection of hepatitis C viral sequences in blood donations by 'nested' polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-22.
8. Hsu HH, Wright TL, Luba D, et al. Failure to detect
hepatitis C virus genome in human secretions with the polymerse chain reaction. Hepatology, 1991;14:763-7.
9. Inchauspe G, abe K, Zebedee S, et al. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by the polymerase chain reaction.
1991; 14: 595-600.
10. Okamato H, Okado S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction. Japan J Exp Med 1990; 60: 215-22.
11. Okamato H, Okado S, Sugiyama Y, et al. The 5' terminal sequences of the hepatitis C virus genome. Japan J Exp Med
1990; 60:167-77.
12. Weiner AJ, Kuo G, Bradley DW, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990;
335:1-3.
13. Lin HJ, Shi N, Mizokami M, et al. Polymerase chain reaction assay for hepatitis C virus using a single tube for reverse transcrioption and serial rounds of amplification with nested primer pairs. J Med Virol 1992; 38: 220-5.
14. Alter MI, Hadler SC, Judson FN. Risk factors for acute non¬A, non-B hepatitis in the USA and association with
hepatitis C virus infection JAMA 1990; 264: 231-5.
15. Fuchs K, Motz M, Scherier E, et al. Characterization of nucleotide sequences from European hepatitis C virus
isolates. Gene 1991; 103:163-9.
16. Han JH, Shyamala V, Richman KH, et al. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly (A) tails at the 3' end. Proc Nat Acad Sci
USA 1991; 1711-5.
17. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloninig of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Nat Acad Sci USA 1990; 87: 9524-8.
18. Ogata N, Alter HJ, Miller RH, et al. Nucleotide sequences
and mutation rate of the H strain of hepatitis C virus. Proc Nat Acad Sci USA. 1991; 88: 3392-6.
19. Takamizawa A, Mori C, Fuke I, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 1105-13.
20. Takeuchi K, Kubo Y, Boonmar S, et al. Putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from and experimentally infected chimpanze and healthy human carriers. J General Virol 1990; 71: 3027-33.
21. Weiner AJ, Truett MA, Rosenblatt J, et al. HCV: immunologic and hybridization-based diagnostics. In
Hollinger FB, Lemon SM, Margolis HS (eds). Viral
Hepatitis and Liver Disease. Baltimore, Williams and
Wilkins 1991; 360-3.
22. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-8.
23. Alter MJ, Mares A, Hadler SC, et al. The effect of
underporting on the apperent incidence and epidemiolgy of acute viral hepatitis. Am J Epidemiol 1987; 125:133-9.
24. Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents and Dis 1993; 2:
1551-66.
25. Feinman SV,Berris B, Bojarski S. Post-tranfusion hepatitis in Toronto, Canada. Gastroenterology 1988; 95: 464-9.
26. Esteban JI, Gonzalez A, Hernandez JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. New Eng J Med 1990; 323: 1107-12.
27. Colombo M, Oldani S, Donato MF, et al. A multicenter, prospective study of posttransfusion hepatitis in Milan.
Hepatology 1987; 7:709-12.
28. Watanabe J, Minegishi K, Mitsumori T, et al. Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox
Sanguinis 1990; 59: 86-8.
29. Aach RD, Szumuness W, Mosley JW. Serum alanine aminotransferase of donors in relation to the risk pf non-A, non-B hepatitis in recipients: the transfusion-transmitted
viruses study. N Eng J Med 1981; 340: 989-94.
30. Koziol DE, Hollan PV, Alling DW. Antibody to hepatitis B
core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;
488-95.
31. Choo QL, Kuo G, Winer AJ, et al. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis
genome. Science 1989; 244: 359-62.
32. Esteban JI, Genesca J, Alter HI. Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features and prevention. In: Boyer JL, Ockner RK (eds). Progress in Liver Diseases, vol 10, Philadelphia, W.B. Saunders Co 1992: 253-82.
33. Simmonds P, Zhang LQ, Watson HG, et al. Hepatitis C quantification and sequences in blood products hemophiliacs and drug users. Lancet 1990;336:1469-72.
34. Ragni MV, Nidimbe OK, Rice EO, et al. The presence of hepatitis C virus antibody in human immunodeficiency virus-positive hemofiliac men undergoing HCV seroconversion. Blood 1993; 82: 1010-5.
35. De Virgilis S, Lai ME, Argiolu F. A prosoective study on post-transfusion non-A,non-B hepatitis in thalassemia children: prevalance of antibody to hepatitis C virus. In:
Hollinger FB, Lemon SM, Margolis HS (eds). Viral
Hepatitis and Liver Diseae. Baltimore: Williams and
Wilkins, 1991:1220-5.
36. Markin M, Preston FE, Triger DR. hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990:1117-9.
37. Everhart JE, Di Biscelige AM, Murray LM. Risk for non-A,
non-B (type C) hepatitis through sexual or hoshold with chronic carriers. Ann Intern Med 1990; 112: 544-5.
38. Nishioka K. Postransfusion hepatitis C. In: Proceedings, Second International Symposium on HCV, Los Angeles,
1990; 36.
39. Arch RD, Cladd ES, Blaine-Hollinger F, Mosley JW,
Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. Hepatitis C virus infection in post-transfusion hepatitis.
An analysis with first and second generation assays. N Eng
Med 1991; 325: 1325-9.
40. Yuki N, Hayashi N, Hagiwara H, et al. Blood screening for asymptomatic hepatitis C virus carriers with second-generation hepatitis C virus assays. In Nishioka K, Suzuki H, Mishioro S, Oda T, (eds). Viral Hepatitis and Liver Disease. Tokyo, Berlin, Heidelbeg, New York, Springer
Verlag 1994;352-4.